Deleterious mutations in SPINK5 in a patient with congenital ichthyosiform erythroderma: molecular testing as a helpful diagnostic tool for Netherton syndrome
- 1 September 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (5) , 513-517
- https://doi.org/10.1111/j.1365-2230.2004.01589.x
Abstract
The congenital erythrodermas represent a heterogeneous group of inherited and acquired disorders often accompanied by systemic infections, impaired epidermal barrier function and concomitant life-threatening fluid and electrolyte imbalance. In the present report, we describe a patient who was considered to have congenital ichthyosiform erythroderma for 26 years until molecular testing led to the correct diagnosis of Netherton syndrome.Keywords
This publication has 26 references indexed in Scilit:
- Squamous cell carcinoma in a patient with Netherton's syndromeInternational Journal of Dermatology, 2002
- Human papillomavirus infection in Netherton's syndromeBritish Journal of Dermatology, 2001
- Clinico-Immunological Heterogeneity in Comèl-Netherton SyndromeDermatology, 2001
- Neonatal and Infantile ErythrodermasArchives of Dermatology, 2000
- Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndromeNature Genetics, 2000
- Localization of the Netherton Syndrome Gene to Chromosome 5q32, by Linkage Analysis and Homozygosity MappingAmerican Journal of Human Genetics, 2000
- LEKTI, a Novel 15-Domain Type of Human Serine Proteinase InhibitorJournal of Biological Chemistry, 1999
- A clinical and immunological study of Netherton's syndromeBritish Journal of Dermatology, 1994
- Neonatal hypernatraemia in two siblings with Netherton's syndromeBritish Journal of Dermatology, 1986
- A Unique Case of Trichorrhexis Nodosa—"Bamboo Hairs"Archives of Dermatology, 1958